Trade Summary

1 week ago, Azamian Bobak R., serving as Pres, CEO, Board Chair at Tarsus Pharmaceuticals, Inc. (TARS), sold 6,000 shares at $82.51 per share, for a total transaction value of $495,089.00. Following this transaction, Azamian Bobak R. now holds 859,741 shares of TARS.

This sale represents a 1.00% decrease in Azamian Bobak R.'s stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, December 24, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, December 30, 2025, 6 days after the trade was made.

Tarsus Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.